Genomics

Dataset Information

0

A mouse model of acute post-surgical pain


ABSTRACT: Pain is the leading cause of disability in the developed world but remains a poorly treated condition. Specifically, post-surgical pain continues to be a frequent and undermanaged condition. Here, we investigate the analgesic potential of pharmacological NaV1.7 inhibition in a mouse model of acute post-surgical pain, based on incision of the plantar skin and underlying muscle of the hind paw. We demonstrate that local and systemic treatment with the selective NaV1.7 inhibitor μ-theraphotoxin-Pn3a is effectively anti-allodynic in this model and completely reverses mechanical hypersensitivity in the absence of motor adverse effects. In addition, the selective NaV1.7 inhibitors ProTx-II and PF-04856264 as well as the clinical candidate CNV1014802 also reduced mechanical allodynia. Interestingly, co-administration of the opioid receptor antagonist naloxone completely reversed analgesic effects of Pn3a, indicating an involvement of endogenous opioids in the analgesic activity of Pn3a. Additionally, we found super-additive antinociceptive effects of sub-therapeutic Pn3a doses not only with the opioid oxycodone but also with the GABAB receptor agonist baclofen. Transcriptomic analysis of gene expression changes in dorsal root ganglia of mice post-surgery revealed decreased expression of several pro-nociceptive genes including N- and P/Q-type voltage-gated calcium channels important for neurotransmitter release, which suggest a reactive compensatory mechanism to reduce excessive pain similar to the endogenous opioid system. In summary, these findings suggest that pain after surgery can be successfully treated with NaV1.7 inhibitors alone or in combination with baclofen or opioids, which may present a novel and safe treatment strategy for this frequent and poorly managed condition.

ORGANISM(S): Mus musculus

PROVIDER: GSE125076 | GEO | 2019/05/01

REPOSITORIES: GEO

Similar Datasets

2014-09-13 | E-GEOD-61373 | biostudies-arrayexpress
2014-09-13 | GSE61373 | GEO
2022-01-01 | GSE159818 | GEO
2023-08-30 | GSE214563 | GEO
2023-05-18 | GSE232804 | GEO
2023-01-23 | GSE223541 | GEO
2020-02-18 | E-MTAB-7503 | biostudies-arrayexpress
2021-07-06 | GSE144832 | GEO
2022-01-03 | GSE117320 | GEO
2022-01-03 | GSE117319 | GEO